Comparison of Synthetic High Density Lipoprotein (HDL) Contrast Agents for MR Imaging of Atherosclerosis

详细信息    查看全文

• 作者：David P. Cormode ; Rohith Chandrasekar ; Amanda Delshad ; Karen C. Briley-Saebo ; Claudia Calcagno ; Alessandra Barazza ; Willem J. M. Mulder ; Edward A. Fisher ; Zahi A. Fayad
• 刊名：Bioconjugate Chemistry
• 出版年：2009
• 出版时间：May 20, 2009
• 年：2009
• 卷：20
• 期：5
• 页码：937-943
• 全文大小：248K
• 年卷期：v.20,no.5(May 20, 2009)
• ISSN：1520-4812

文摘

Determining arterial macrophage expression is an important goal in the molecular imaging of atherosclerosis. Here, we compare the efficacy of two synthetic, high density lipoprotein (HDL) based contrast agents for magnetic resonance imaging (MRI) of macrophage burden. Each form of HDL was labeled with gadolinium and rhodamine to allow MRI and fluorescence microscopy. Either the 37 or 18 amino acid peptide replaced the apolipoprotein A-I in these agents, which were termed 37pA-Gd or 18A-Gd. The diameters of 37pA-Gd and 18A-Gd are 7.6 and 8.0 nm, respectively, while the longitudinal relaxivities are 9.8 and 10.0 (mM s)⁻¹. 37pA has better lipid binding properties. In vitro tests with J774A.1 macrophages proved the particles possessed the functionality of HDL by eliciting cholesterol efflux and were taken up in a receptor-like fashion by the cells. Both agents produced enhancements in atherosclerotic plaques of apolipoprotein E knockout mice of 90% (n = 7 per agent) and are macrophage specific as evidenced by confocal microscopy on aortic sections. The half-lives of 37pA-Gd and 18A-Gd are 2.6 and 2.1 h, respectively. Despite the more favorable lipid interactions of 37pA, both agents gave similar, excellent contrast for the detection of atherosclerotic macrophages using MRI.